Model Number N/A |
Device Problem
Unsealed Device Packaging (1444)
|
Patient Problems
No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
|
Event Date 10/23/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4).Report source: foreign.The event occurred in (b)(6).Pma 510(k): the product within this report is a combination product.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Not returned to manufacturer.
|
|
Event Description
|
It was reported sterile packaging is not fully sealed, resulting in the package contents spilling out so it could not be used anymore.
|
|
Manufacturer Narrative
|
(b)(4).This follow-up report is being submitted to relay additional information.Corrective action has been initiated for the reported issue.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.The device analysis can't be performed as the product location is unknown.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|
|
Event Description
|
It has been reported that the sterile packaging was not fully sealed, resulting in the package contents spilling out so it could not be used anymore.
|
|
Manufacturer Narrative
|
(b)(4).This follow-up report is being submitted to relay additional information.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|
|
Event Description
|
It was reported that the sterile packaging was not fully sealed, resulting in the package contents spilling out so it could not be used anymore.The event occured in 3 products.
|
|
Manufacturer Narrative
|
(b)(4) this follow-up report is being submitted to relay additional information.The following sections were updated: b4, b5, d10, g4, h1, h2, h3, h6, h10.Three complaint samples were received and evaluated and the reported event was confirmed.Evaluation of returned devices found that the sealings were opened.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.No similar complaint has been recorded for refobacin bone cement r 2x40g, reference (b)(4), batch a552ck1626 within one year.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|
|
Search Alerts/Recalls
|